195 related articles for article (PubMed ID: 16982690)
21. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
22. Selective contribution of Tyk2 to cell activation by lipopolysaccharide.
Schneider A; Reichart U; Gerner W; Kolbe T; Saalmüller A; Müller M
FEBS Lett; 2008 Oct; 582(25-26):3681-6. PubMed ID: 18845149
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses.
Fuchs S; Kaiser-Labusch P; Bank J; Ammann S; Kolb-Kokocinski A; Edelbusch C; Omran H; Ehl S
Eur J Immunol; 2016 Nov; 46(11):2639-2649. PubMed ID: 27615517
[TBL] [Abstract][Full Text] [Related]
24. Structural and Functional Characterization of the JH2 Pseudokinase Domain of JAK Family Tyrosine Kinase 2 (TYK2).
Min X; Ungureanu D; Maxwell S; Hammarén H; Thibault S; Hillert EK; Ayres M; Greenfield B; Eksterowicz J; Gabel C; Walker N; Silvennoinen O; Wang Z
J Biol Chem; 2015 Nov; 290(45):27261-27270. PubMed ID: 26359499
[TBL] [Abstract][Full Text] [Related]
25. TYK2, a Candidate Gene for Type 1 Diabetes, Modulates Apoptosis and the Innate Immune Response in Human Pancreatic β-Cells.
Marroqui L; Dos Santos RS; Fløyel T; Grieco FA; Santin I; Op de Beeck A; Marselli L; Marchetti P; Pociot F; Eizirik DL
Diabetes; 2015 Nov; 64(11):3808-17. PubMed ID: 26239055
[TBL] [Abstract][Full Text] [Related]
26. Control of Leishmania major in the absence of Tyk2 kinase.
Schleicher U; Mattner J; Blos M; Schindler H; Röllinghoff M; Karaghiosoff M; Müller M; Werner-Felmayer G; Bogdan C
Eur J Immunol; 2004 Feb; 34(2):519-29. PubMed ID: 14768057
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
[TBL] [Abstract][Full Text] [Related]
28. The impact of tyrosine kinase 2 (Tyk2) on the proteome of murine macrophages and their response to lipopolysaccharide (LPS).
Radwan M; Miller I; Grunert T; Marchetti-Deschmann M; Vogl C; O'Donoghue N; Dunn MJ; Kolbe T; Allmaier G; Gemeiner M; Müller M; Strobl B
Proteomics; 2008 Sep; 8(17):3469-85. PubMed ID: 18683816
[TBL] [Abstract][Full Text] [Related]
29. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
[TBL] [Abstract][Full Text] [Related]
30. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18.
Sugimoto N; Nakahira M; Ahn HJ; Micallef M; Hamaoka T; Kurimoto M; Fujiwara H
Eur J Immunol; 2003 Jan; 33(1):243-51. PubMed ID: 12594853
[TBL] [Abstract][Full Text] [Related]
31. Tyk2 deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.
Ishizaki M; Muromoto R; Akimoto T; Ohshiro Y; Takahashi M; Sekine Y; Maeda H; Shimoda K; Oritani K; Matsuda T
Int Immunol; 2011 Sep; 23(9):575-82. PubMed ID: 21765170
[TBL] [Abstract][Full Text] [Related]
32. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction.
Velazquez L; Mogensen KE; Barbieri G; Fellous M; Uzé G; Pellegrini S
J Biol Chem; 1995 Feb; 270(7):3327-34. PubMed ID: 7531704
[TBL] [Abstract][Full Text] [Related]
33. Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta.
Barbieri G; Velazquez L; Scrobogna M; Fellous M; Pellegrini S
Eur J Biochem; 1994 Jul; 223(2):427-35. PubMed ID: 8055912
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27.
Bosmann M; Strobl B; Kichler N; Rigler D; Grailer JJ; Pache F; Murray PJ; Müller M; Ward PA
J Leukoc Biol; 2014 Jul; 96(1):123-31. PubMed ID: 24604832
[TBL] [Abstract][Full Text] [Related]
35. Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity.
Derecka M; Gornicka A; Koralov SB; Szczepanek K; Morgan M; Raje V; Sisler J; Zhang Q; Otero D; Cichy J; Rajewsky K; Shimoda K; Poli V; Strobl B; Pellegrini S; Harris TE; Seale P; Russell AP; McAinch AJ; O'Brien PE; Keller SR; Croniger CM; Kordula T; Larner AC
Cell Metab; 2012 Dec; 16(6):814-24. PubMed ID: 23217260
[TBL] [Abstract][Full Text] [Related]
36. Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes.
Vogl C; Flatt T; Fuhrmann B; Hofmann E; Wallner B; Stiefvater R; Kovarik P; Strobl B; Müller M
BMC Genomics; 2010 Mar; 11():199. PubMed ID: 20338026
[TBL] [Abstract][Full Text] [Related]
37. CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
Herrmann A; Lahtz C; Nagao T; Song JY; Chan WC; Lee H; Yue C; Look T; Mülfarth R; Li W; Jenkins K; Williams J; Budde LE; Forman S; Kwak L; Blankenstein T; Yu H
Cancer Res; 2017 Sep; 77(18):5118-5128. PubMed ID: 28716895
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity.
Strobl B; Stoiber D; Sexl V; Mueller M
Front Biosci (Landmark Ed); 2011 Jun; 16(9):3214-32. PubMed ID: 21622231
[TBL] [Abstract][Full Text] [Related]
39. IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17-Regulated mRNA Stabilization.
Muromoto R; Tawa K; Ohgakiuchi Y; Sato A; Saino Y; Hirashima K; Minoguchi H; Kitai Y; Kashiwakura JI; Shimoda K; Oritani K; Matsuda T
Immunohorizons; 2019 May; 3(5):172-185. PubMed ID: 31356171
[TBL] [Abstract][Full Text] [Related]
40. Induction of beta-R1/I-TAC by interferon-beta requires catalytically active TYK2.
Rani MR; Gauzzi C; Pellegrini S; Fish EN; Wei T; Ransohoff RM
J Biol Chem; 1999 Jan; 274(4):1891-7. PubMed ID: 9890942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
